IRCT138901203667N1
Effects of selenium on oxidative stress and glycemic control of type 2 diabetes
Vice-chancellor for Research, Tehran University of Medical Sciences·Phase 4·Iranian Registry Of Clinical Trial·drugCompleted
Study focus
- Disease/Condition
- Diabetes Mellitus
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Vice-chancellor for Research, Tehran University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 4
- Start date
- Feb 20, 2010
- End date
- N/A
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT138901203667N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT138901203667N1 through Pure Global AI's free database. This Phase 4 trial is sponsored by Vice-chancellor for Research, Tehran University of Medical Sciences and is currently Completed. The study focuses on Diabetes Mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.